comparemela.com
Home
Live Updates
Prnewswire Chordia Therapeutics Inc - Breaking News
Pages:
Latest Breaking News On - Prnewswire chordia therapeutics inc - Page 1 : comparemela.com
Chordia Therapeutics Announces Interim Results of the Phase 1 Clinical Trial of CLK Inhibitor CTX-712 at the 2022 ASCO Annual Meeting
/PRNewswire/ Chordia Therapeutics Inc. ("Chordia"), a biotech company engaged in the research and development of novel therapies for cancers, today.
United states
Noboru yamamoto
Hiroshi miyake
National cancer center hospital
Chordia therapeutics inc
Prnewswire chordia therapeutics inc
Department of experimental therapeutics
Shonan health innovation park
American society
Clinical oncology
Experimental therapeutics
Principal investigator
First in human phase
Refractory malignant
Arginine rich proteins
Chordia therapeutics
vimarsana © 2020. All Rights Reserved.